In cancer cells, the N-terminal domain of E1A represses MYC transcription through pathways involving targeting of both p300 and TRRAP, as well as inhibition of H3K18 and H4K16 acetylation, at the MYC promoter. The gene discussed is MYC; the disease is cancer.